Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06596447 · ClinicalTrials.gov registry record

Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation

A clinical trial of Obsessive Compulsive Disorder (OCD) and Neuromodulation, sponsored by Baylor College of Medicine.

Recruiting
Registry status
10
Enrollment target
2
Study locations

NCT06596447 is a study of Obsessive Compulsive Disorder (OCD) and Neuromodulation that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 10 participants, below the 243-participant average among 12 other Obsessive Compulsive Disorder (OCD) trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06596447, a study of Obsessive Compulsive Disorder (OCD) and Neuromodulation, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
10 participants
Enrollment target
2
Study locations

Study Summary

We will recruit 10 patients with OCD meeting established criteria for surgical evaluation. Following informed consent and baseline evaluations, each will be implanted with permanent DBS SenSight leads and the Medtronic Percept RC IPG, which has on-device neural recording capability and rechargeability. We will collect a broad array of neurobehavioral data across two environments with complementary advantages: the clinic and the home. The first 2 Aims test our mechanistic hypothesis by studying the pattern of VS neural activity in the controlled environment of the lab/clinic during two complementary paradigms: one based on a psychophysical behavioral task, the other based on ERP, a therapeutic behavioral intervention. The third aim tests this hypothesis in an ambulatory, naturalistic setting with chronic neural on-device recordings paired with time resolved behavioral measures. We will investigate a possible common neural basis underlying approach and avoidance across these 3 paradigms. Subjects will participate in research at 7 critical timepoints during routine clinic visits (Fig. 4): before implant, 1 day before DBS activation, immediately after DBS activation, 2 weeks, 3 months, 6 months, and 12 months after DBS initiation. At these timepoints, patients will complete clinical assessments, perform the Probabilistic Approach Avoidance Task (PAAT), and conduct exposure trials under the guidance of a psychologist. The clinic offers the most controlled environment and provides opportunities for collecting high temporal resolution behavior synchronized to local field potential (LFP) recordings. These data will allow us to identify the degree of overlap in the time-resolved neural activity driving individual decisions to approach potential rewards or avoid potential aversive stimuli (Aim 1), and resist performing compulsions in order to achieve relief after OCD symptoms are triggered (Aim 2). At home, our goal is to investigate patient trajectories along the approach

Interventions

  • DEVICE Deep Brain Stimulation

Study Locations (2)

Texas

  • Baylor College of Medicine - Houston
  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-03-01
Est. Completion 2030-03

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT06596447

The ClinicalTrials.gov registry entry for NCT06596447 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 243-participant average among 12 other Obsessive Compulsive Disorder (OCD) trials with a reported enrollment target (96% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obsessive Compulsive Disorder (OCD) appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation is the first listed.

NCT06596447 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06596447 about?

NCT06596447 is a clinical study titled "Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation". We will recruit 10 patients with OCD meeting established criteria for surgical evaluation. Following informed consent and baseline evaluations, each will be implanted with permanent DBS SenSight leads and the Medtronic Percept RC IPG, which has on-device neural recording capability and rechargeabili...

What is the current status of trial NCT06596447?

This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-03-01. Estimated completion is 2030-03.

What conditions does trial NCT06596447 study?

This clinical trial studies the following conditions: Obsessive Compulsive Disorder (OCD), Neuromodulation.

What interventions are being tested in trial NCT06596447?

The interventions under investigation include: Deep Brain Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06596447?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06596447 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive Compulsive Disorder (OCD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.